MSME (Udyam registered) Ministry of MSME
- Category
- Small (2022-23)
- Udyam number
- UDYAM-TS-20-0004529
Jayanth Pharmaceuticals Private Limited
Jayanth Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹12.36 Cr
▼ 2% YoY
Net profit · FY 2025
₹51.99 Lakh
Net margin 4.2%
EBITDA · FY 2025
₹1.87 Cr
EBITDA margin 15.2%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹2 Cr
Issued & subscribed
Open charges
₹25.19 Cr
Satisfied ₹12.24 Cr
Company age
24 yrs
Est. 2002
Employees · EPFO
13
Provident fund records
About Jayanth Pharmaceuticals Private Limited
Data last updated:
Jayanth Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 January 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2002PTC038432. Its GSTIN is 36AABCJ3135B1Z5 (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors including Koti Reddy Baireddy (Managing Director) and Ravi Teja Reddy Baireddy (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pl.No 4A Phase 1 Ida Cherlapally, Hyderabad, Telangana, India – 500051.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.36 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹51.99 Lakh (net margin 4.2%) and EBITDA of ₹1.87 Cr (EBITDA margin 15.2%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 27% over five years.
The company has about 13 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹25.19 Cr and satisfied charges of ₹12.24 Cr on record.
Jayanth Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0004529). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24239TG2002PTC038432
Registration Number 038432
Incorporation Date 31 January 2002
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0004529
CIN history
Jayanth Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239AP2002PTC038432. The current CIN is U24239TG2002PTC038432, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2002PTC038432 | Current |
| U24239AP2002PTC038432 | Previous |
Key People
Koti Reddy Baireddy Managing Director Ravi Teja Reddy Baireddy Whole-Time Director Nitya Dasaram Whole-Time Director Recognitions & Rankings of Jayanth Pharmaceuticals
Contact details
Jayanth Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPl.No 4A Phase 1 Ida Cherlapally, Hyderabad, Telangana, India – 500051
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Jayanth Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Jayanth Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Jayanth Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Jayanth Pharmaceuticals Private Limited, buy the company report.
Financials of Jayanth Pharmaceuticals Private Limited
FY 2025 filings availableJayanth Pharmaceuticals Private Limited reported revenue of ₹12.36 Cr (down 2% YoY) for FY 2025.
Revenue · FY 2025
₹12.36 Cr ▼ 2%
Net profit · FY 2025
₹51.99 Lakh margin 4.2%
EBITDA · FY 2025
₹1.87 Cr margin 15.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 16%
5 years · compounded
▲ 27%
EBITDA CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 21%
5 years · compounded
▲ 19%
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 27%. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.87 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹51.99 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.2% | ||||
| Net Profit Margin | 4.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jayanth Pharmaceuticals Private Limited, buy the company report.
Board of directors of Jayanth Pharmaceuticals Private Limited
Jayanth Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Teja Reddy Baireddy Also directs: J.K. Chemlabs Private Limited | Whole-Time Director | 30 Sep 2018 | 8 Years 0 Months | Current |
| Nitya Dasaram Also directs: J.K. Chemlabs Private Limited | Whole-Time Director | 30 Sep 2018 | 8 Years 0 Months | Current |
| Koti Reddy Baireddy | Managing Director | 31 Jan 2002 | 24 Years 8 Months | Current |
| Baireddy Jaya | Whole-Time Director | 19 May 2018 | 8 Years 5 Months | Current |
Peer comparison
Jayanth Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Xenone Healthcare Private Limited | ₹12.47 Cr (FY 2024) | 16.0% | New Delhi, Delhi, India | |||
| Unisafe Bioscience Private Limited | ₹12.44 Cr (FY 2025) | -1.0% | Ahmedabad, Gujarat, India | |||
| ZRS Pharmaceuticals India Private Limited | ₹12.41 Cr (FY 2025) | 63.0% | Delhi, India | |||
| Jayanth Pharmaceuticals Private Limitedthis company | ₹12.36 Cr (FY 2025) | ₹51.99 Lakh | 4.2% | -2.0% | 13 | Hyderabad, Telangana, India |
| Avicura Pharmaceuticals Private Limited | ₹12.32 Cr (FY 2025) | 5.0% | Thane, Maharashtra, India | |||
| Austex Pharmaceutical Private Limited | ₹12.27 Cr (FY 2025) | 12.0% | Howrah, West Bengal, India |
To see the full peer comparison of Jayanth Pharmaceuticals Private Limited, buy the company report.
Auditor
Jayanth Pharmaceuticals Private Limited is audited by S.N.M NANDURY & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.N.M NANDURY & CO. | FY 2023 | 006199S |
Shareholding
The shareholding of Jayanth Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Jayanth Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹25.19 Cr
Satisfied charges
₹12.24 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Mar 2023 | 100708403 | Indian Bank | ₹8.2 Cr | Open | |
| 19 Oct 2022 | 100628249 | Indian Bank | ₹16.88 Cr | Open | |
| 31 May 2022 | 100593595 | Hdfc Bank Limited | ₹11.73 Lakh | Open | |
| 25 Oct 2021 | 100500794 | Others | ₹3.25 Cr | Satisfied | |
| 25 Sep 2021 | 100496708 | Others | ₹1.35 Cr | Satisfied |
To see the full charge records of Jayanth Pharmaceuticals Private Limited, buy the company report.
Total charge records: 17 View all charges
Legal cases
No court or tribunal cases involving Jayanth Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jayanth Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Jayanth Pharmaceuticals Private Limited has a workforce of 13 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
13
Active EPFO establishments
1
Employee growth
8.33%
GST
Jayanth Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCJ3135B1Z5 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Jayanth Pharmaceuticals Private Limited, buy the company report.
Recent activity
Jayanth Pharmaceuticals Private Limited has 7 board changes on record since 2002: 4 appointments and 3 cessations. The latest: Baireddy Jaya ceased to be Additional Director on 30 Sep 2018.
AGM
Jayanth Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 16 Aug 2021 via Charge ID 100471379 with Axis Bank Limited was fully satisfied on 21 Aug 2025.
Filing
Jayanth Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge registered on 25 Oct 2021 via Charge ID 100500794 with Others was fully satisfied on 24 May 2023.
Charges
A charge with Indian Bank amounted to Rs. 8.20 Cr with Charge ID 100708403 was registered on 31 Mar 2023.
Charges
A charge with Indian Bank amounted to Rs. 16.88 Cr with Charge ID 100628249 was registered on 19 Oct 2022.
Charges
A charge registered on 25 Sep 2021 via Charge ID 100496708 with Others was fully satisfied on 03 Oct 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.12 Cr with Charge ID 100593595 was registered on 31 May 2022.
Charges
A charge registered on 03 Nov 2020 via Charge ID 100392756 with Axis Bank Limited was fully satisfied on 27 Dec 2021.
Charges
A charge registered on 16 Dec 2019 via Charge ID 100313810 with Axis Bank Limited was fully satisfied on 27 Dec 2021.
Charges
A charge registered on 26 Jun 2019 via Charge ID 100276532 with Axis Bank Limited was fully satisfied on 27 Dec 2021.
Charges
A charge with Others amounted to Rs. 3.25 Cr with Charge ID 100500794 was registered on 25 Oct 2021.
30 earlier events are in the company report.
Frequently asked questions
Jayanth Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 January 2002 (24+ years old) and is registered under CIN U24239TG2002PTC038432.
Jayanth Pharmaceuticals has 4 current directors:
- Koti Reddy Baireddy - Managing Director
- Ravi Teja Reddy Baireddy - Whole-Time Director
- Nitya Dasaram - Whole-Time Director
- Baireddy Jaya - Whole-Time Director
The latest financial statements of Jayanth Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Jayanth Pharmaceuticals is 36AABCJ3135B1Z5, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Jayanth Pharmaceuticals is U24239TG2002PTC038432. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jayanth Pharmaceuticals was incorporated on 31 January 2002, making it 24+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Jayanth Pharmaceuticals by revenue are Xenone Healthcare Private Limited, Unisafe Bioscience Private Limited, ZRS Pharmaceuticals India Private Limited, Avicura Pharmaceuticals Private Limited, Austex Pharmaceutical Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Baireddy Jaya ceased to be Additional Director on 30 Sep 2018. Nitya Dasaram was appointed as Whole-Time Director on 30 Sep 2018. Ravi Teja Reddy Baireddy was appointed as Whole-Time Director on 30 Sep 2018. Jayanth Pharmaceuticals has 7 board changes on record in total.
Yes, Jayanth Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0004529).
The registered office of Jayanth Pharmaceuticals is at Pl.No 4A Phase 1 Ida Cherlapally, Hyderabad, Telangana, India – 500051.
Jayanth Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.